Markets in Asia and Europe move higher, while crude hovers at about $100 a barrel amid cautious optimism Business live – latest updates The price of oil has dipped and Asian stock markets moved higher after reports that Donald Trump has sent a 15-point framework for peace to Iran, amid hopes of a ceasefire in the Middle East. Oil prices had fallen by 4% in the early hours of Wednesday, with brent ...
Markets in Asia and Europe move higher, while crude hovers at about $100 a barrel amid cautious optimism Business live – latest updates The price of oil has dipped and Asian stock markets moved higher after reports that Donald Trump has sent a 15-point framework for peace to Iran, amid hopes of a ceasefire in the Middle East. Oil prices had fallen by 4% in the early hours of Wednesday, with brent crude futures sinking below $100 a barrel and even moving as low as $97.57 as trading was influenced by the prospect of an end to the conflict easing the squeeze on oil supply. Continue reading...
The market landscape is increasingly controlled by large firms that expand their reach by acquiring smaller competitors - a trend that the Trump administration’s looser regulatory policies will likely intensify. But a handful of under-the-radar players will persist by leaning into their niches.
The market landscape is increasingly controlled by large firms that expand their reach by acquiring smaller competitors - a trend that the Trump administration’s looser regulatory policies will likely intensify. But a handful of under-the-radar players will persist by leaning into their niches.
The bulls have been running wild on Wall Street since the Dow Jones Industrial Average (DJINDICES: ^DJI) , S&P 500 (SNPINDEX: ^GSPC) , and Nasdaq Composite (NASDAQINDEX: ^IXIC) bottomed during the financial crisis 17 years ago. With the exception of the five-week COVID-19 crash in February-March 2020 and the nine-month bear market in 2022, optimism has ruled the roost. But over a century of histor...
The bulls have been running wild on Wall Street since the Dow Jones Industrial Average (DJINDICES: ^DJI) , S&P 500 (SNPINDEX: ^GSPC) , and Nasdaq Composite (NASDAQINDEX: ^IXIC) bottomed during the financial crisis 17 years ago. With the exception of the five-week COVID-19 crash in February-March 2020 and the nine-month bear market in 2022, optimism has ruled the roost. But over a century of history tells us that stock market cycles are normal, healthy, and inevitable. At some point, Wall Street's bull market run is going to give way to a bear market . Based on a recently highlighted signal from one of the stock market's leading optimists, the music may be stopping for the Dow, S&P 500, and Nasdaq Composite in the not-too-distant future. Image source: Getty Images. Continue reading
Earnings Call Insights: Paysign, Inc. (PAYS) Q4 2025 Management View Mark Newcomer, President and CEO, reported "continued strength and exceptional growth across all key metrics," noting full-year revenue increased 40.5% to $82 million, net income rose 98% to $7.6 million, and adjusted EBITDA grew 107% to $19.9 million. Operating margins increased by 723 basis points, signaling a key inflection po...
Earnings Call Insights: Paysign, Inc. (PAYS) Q4 2025 Management View Mark Newcomer, President and CEO, reported "continued strength and exceptional growth across all key metrics," noting full-year revenue increased 40.5% to $82 million, net income rose 98% to $7.6 million, and adjusted EBITDA grew 107% to $19.9 million. Operating margins increased by 723 basis points, signaling a key inflection point in profitability and operating leverage. Newcomer highlighted that the patient affordability business saw annual revenue grow 168% year-over-year to $33.9 million, with claims processed up approximately 79%. He stated the platform "helped deliver nearly $1 billion in financial assistance to patients" and that their dynamic business rules technology "saved our clients over $325 million" in 2025, with $150 million saved already in the current year. The company added 55 programs during the year, bringing total active programs to 131 and now works with 6 of the top 10 U.S. pharmaceutical manufacturers. Newcomer emphasized ongoing expansion within existing client relationships and a robust pipeline ahead of the Asembia Specialty Pharmacy Summit. Matthew Turner, President of Patient Affordability, addressed concerns over direct-to-consumer and pharmacy discount programs, stating these models are "not a meaningful substitute for our core business" and that "demand for our dynamic business rule solutions... continues to grow." On the plasma donor compensation business, Newcomer reported revenue of $45.6 million, up 4% year-over-year, with the company exiting 2025 with 595 centers and a market share just under 50%. He pointed to additional growth opportunities through donor management tools and anticipated FDA review of their donor management system. Jeffery Baker, CFO, stated, "total revenues increased 40.5% to $82 million. Pharma industry revenue increased 167.8% to $33.9 million," driven by "the addition of 55 net patient affordability programs launched during the past 12 mon...